Tenn. Code § 63-6-309

Current through Acts 2023-2024, ch. 1069

Section 63-6-309 - Reporting of adverse events

If a patient suffers an adverse event associated with the use of an investigational drug, biological product, or device, the patient's physician shall report the adverse event to the manufacturer of the investigational drug, biological product, or device.

T.C.A. § 63-6-309

Added by 2015 Tenn. Acts, ch. 376, s 1, eff. 7/1/2015.